From: Xanthine oxidoreductase gene polymorphisms are associated with high risk of sepsis and organ failure
SNPs | RegulomedB rank (score) | eQTLs (GTEx) Tissue-specific p ≤ 0.05 | SiNoPsis* | CADD (scaled) | Relevance for sepsis |
---|---|---|---|---|---|
rs206816 | Other (7, 0.18412) | 9 tissues (in cultured fibroblasts: p = 3.8e-7) |  | 2.26 | Associated with XOR activity among sepsis patients with ARDS |
rs7575607 | Other (7, 0.51392) | 11 tissues (in cultured fibroblasts: p = 7.2e-6) |  | 0.783 |  |
rs206811 | eQTL + TF binding/DNase peak (1f, 0.55436) | 8 tissues (in cultured fibroblasts: p = 3.5e-6) |  | 1.22 |  |
rs206805 | Other (7, 0.51392) | 5 tissues | Â | 1.81 | Associated with risk of sepsis |
rs1366814 | eQTL + TF binding/DNase peak (1f, 0.08217) | 2 tissues |  | 0.446 |  |
rs513311 | eQTL + TF binding/DNase peak (1f, 0.66703) |  |  | 1.58 | Associated with risk of sepsis & replicated in the GEN-SEP cohort |
rs6714794 | eQTL + TF binding/DNase peak (1f, 0.55436) | 1 tissue |  | 5.17 |  |
rs206859 | eQTL + TF binding/DNase peak (1f, 0.19549) | 9 tissues (in cultured fibroblasts: p = 3.3e-6) |  | 4.12 |  |
rs206849 | eQTL + TF binding/DNase peak (1f, 0.66703) | 5 tissues | creSNP | 0.841 | Associated with XOR activity among sepsis patients with ARDS |
rs13418515 | Other (7, 0.51392) | 2 tissues | Â | 4.05 | Â |
rs185925 | eQTL + TF binding/DNase peak (1f, 0.55436) | 7 tissues (in cultured fibroblasts: p = 1.3e-5) |  | 6.84 | Associated with risk of sepsis and XOR activity |
rs561525 | TF binding or DNase peak (5, 0.13454) | Â | Â | 0.0560 | Associated with risk of sepsis & replicated in the GEN-SEP cohort |
rs17011403 | TF binding + DNase peak (4, 0.60906) |  |  | 0.192 |  |
rs1864280 | eQTL + TF binding + any motif + DNase footprint + DNase peak (1b, 0.98786) | 3 tissues | creSNP | 6.25 |  |
rs2163059 | eQTL + TF binding + any motif + DNase footprint + DNase peak (1b, 0.99571) | 1 tissue |  | 0.339 | Associated with risk of sepsis & replicated in the GEN-SEP cohort |
rs2281547 | eQTL + TF binding/DNase peak (1f, 0.22271) | 3 tissues |  | 6.05 |  |
rs1366817 | Other (7, 0.51392) | 3 tissues | Â | 5.68 | Â |
rs17011368 | TF binding or DNase peak (5, 0.13454) | Â | Â | 22.4 | Associated with mortality among sepsis patients with ARDS |
rs2281550 | eQTL + TF binding/DNase peak (1f, 0.22271) | 2 tissues |  | 0.975 |  |
rs13387204 | eQTL + TF binding/DNase peak (1f, 0.08) | 2 tissues |  | 6.54 | Associated with risk of sepsis |
rs12621192 | eQTL + TF binding/DNase peak (1f, 0.22271) | 3 tissues |  | 0.429 |  |
rs1884725 | eQTL + TF binding/DNase peak (1f, 0.02) | 1 tissue |  | 11.5 | Associated with renal dysfunction among sepsis patients |
rs4952085 | eQTL + TF binding/DNase peak (1f, 0.55436) | 1 tissue | creSNP | 0.307 | |
rs207432 | eQTL + TF binding/DNase peak (1f, 0.55436) | 2 tissues |  | 0.844 |  |
rs207431 | TF binding or DNase peak (5, 0.64) | Â | Â | 0.0120 | Â |
rs932559 | Motif hit (6, 0.0575) | 1 tissue | Â | 2.52 | Â |
rs12478111 | eQTL + TF binding/DNase peak (1f, 0.22271) | 1 tissue |  | 0.839 |  |
rs6756897 | eQTL + TF binding/DNase peak (1f, 0.55324) | 2 tissues |  | 1.19 |  |